1-substituted-4-nitroimidazole compound and process for producing the same
申请人:Goto Fumitake
公开号:US20060079697A1
公开(公告)日:2006-04-13
The present invention relates to a 1-substituted-4-nitroimidazole compound represented by the general formula (1) or a salt thereof,
(wherein R is a hydrogen atom, a lower alkoxy group-substituted lower alkyl group, a phenyl-lower alkoxy group-substituted lower alkyl group, a cyano-substituted lower alkyl group, a phenyl-lower alkyl group which may have lower alkoxy groups as the substituents in the phenyl ring or a group of the formula —CH
2
R
A
; X is a halogen atom or a group of the formula —S(O)n—R
1
) and method for preparing the same. The compound of the formula (1) is a useful compound as an intermediate for synthesis of various pharmaceutical and agricultural chemicals, particularly, as intermediates for antitubercular agents.
1-Substituted-4-nitroimidazole compound and method for preparing the same
申请人:Goto Fumitaka
公开号:US20080200689A1
公开(公告)日:2008-08-21
The present invention relates to a 1-substituted-4-nitroimidazole compound represented by the general formula (1) or a salt thereof,
(wherein R is a hydrogen atom, a lower alkoxy group-substituted lower alkyl group, a phenyl-lower alkoxy group-substituted lower alkyl group, a cyano-substituted lower alkyl group, a phenyl-lower alkyl group which may have lower alkoxy groups as the substituents in the phenyl ring or a group of the formula —CH
2
R
A
; X is a halogen atom or a group of the formula —S(O)n-R
1
) and method for preparing the same. The compound of the formula (1) is a useful compound as an intermediate for synthesis of various pharmaceutical and agricultural chemicals, particularly, as intermediates for antitubercular agents.
1-substituted-4-nitroimidazole compound and method for preparing the same
申请人:Goto Fumitaka
公开号:US20080097107A1
公开(公告)日:2008-04-24
The present invention relates to a 1-substituted-4-nitroimidazole compound represented by the general formula (1) or a salt thereof,
(wherein R is a hydrogen atom, a lower alkoxy group-substituted lower alkyl group, a phenyl-lower alkoxy group-substituted lower alkyl group, a cyano-substituted lower alkyl group, a phenyl-lower alkyl group which may have lower alkoxy groups as the substituents in the phenyl ring or a group of the formula —CH
2
R
A
; X is a halogen atom or a group of the formula —S(O)n-R
1
) and method for preparing the same. The compound of the formula (1) is a useful compound as an intermediate for synthesis of various pharmaceutical and agricultural chemicals, particularly, as intermediates for antitubercular agents.
PROCESS FOR PRODUCTION OF 2-CHLORO-4-NITROIMIDAZOLE
申请人:Shinhama Koichi
公开号:US20090082575A1
公开(公告)日:2009-03-26
The present invention provides a process for production of 2-chloro-4-nitroimidazole in a high yield and at a high purity by a simple operation in a safer manner involving a low risk of explosion or the like. The present invention provides a process for production of 2-chloro-4-nitroimidazole represented by the formula (1): comprising a reaction of a 1-alkoxyalkyl-2-bromo-4-nitroimidazole compound represented by the general formula (7): wherein R1 represents a lower alkyl group, and n represents an integer of 1 to 3, with hydrogen chloride.
1-Substituted-4-Nitroimidazole Compound and Method for Preparing the Same
申请人:GOTO Fumitaka
公开号:US20120130082A1
公开(公告)日:2012-05-24
The present invention relates to a 1-substituted-4-nitroimidazole compound represented by the general formula (1) or a salt thereof,
(wherein R is a hydrogen atom, a lower alkoxy group-substituted lower alkyl group, a phenyl-lower alkoxy group-substituted lower alkyl group, a cyano-substituted lower alkyl group, a phenyl-lower alkyl group which may have lower alkoxy groups as the substituents in the phenyl ring or a group of the formula —CH
2
R
A
; X is a halogen atom or a group of the formula —S(O)n-R
1
) and method for preparing the same. The compound of the formula (1) is a useful compound as an intermediate for synthesis of various pharmaceutical and agricultural chemicals, particularly, as intermediates for antitubercular agents.